https://www.selleckchem.com/products/ck-586.html
09; 95% CI -0.14, -0.03, p=0.002 for MMSE; β -0.04; 95% CI -0.06, -0.02; p0.001 for FAB; β -4.15; 95% CI -5.64, -2.66; p0.001 for RBANS) in addition to all domains of the RBANS. Regular benzodiazepine use was also associated with poorer neuropsychological test performance, especially in Immediate Memory (β -4.98; 95% CI -6.81, -3.15; p0.001) and Attention (β -6.81; 95% CI -8.60, -5.03; p0.001) RBANS domains. Regular use of definite anticholinergic medications and benzodiazepines, but not potential anticholinergics or "Z-d
Like
Comment
Share
